EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 72 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $38,836 | -24.0% | 43,300 | 0.0% | 0.00% | – |
Q4 2022 | $51,094 | -81.1% | 43,300 | +20.3% | 0.00% | – |
Q3 2022 | $271,000 | +29.7% | 36,000 | +8.4% | 0.00% | – |
Q2 2022 | $209,000 | -14.3% | 33,200 | +12.9% | 0.00% | – |
Q1 2022 | $244,000 | +59.5% | 29,400 | 0.0% | 0.00% | – |
Q4 2021 | $153,000 | -26.8% | 29,400 | -6.1% | 0.00% | – |
Q3 2021 | $209,000 | -21.7% | 31,300 | 0.0% | 0.00% | – |
Q2 2021 | $267,000 | +0.4% | 31,300 | +4.3% | 0.00% | – |
Q1 2021 | $266,000 | -27.9% | 30,000 | 0.0% | 0.00% | – |
Q4 2020 | $369,000 | +51.2% | 30,000 | 0.0% | 0.00% | – |
Q3 2020 | $244,000 | -15.3% | 30,000 | 0.0% | 0.00% | – |
Q2 2020 | $288,000 | +119.8% | 30,000 | +55.4% | 0.00% | – |
Q1 2020 | $131,000 | -14.4% | 19,300 | +87.4% | 0.00% | – |
Q4 2019 | $153,000 | +44.3% | 10,300 | 0.0% | 0.00% | – |
Q3 2019 | $106,000 | – | 10,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |